https://www.selleckchem.com/pr....oducts/brensocatib.h
COVID-19-associated coagulopathy is most often characterized by elevated D-dimer, interleukin-6 and plasma fibrinogen concentration as well as hypercoagulability in thromboelastometry with increase clot firmness in EXTEM, INTEM and FIBTEM. Clinically, it strikes with a very high incidence of thrombosis, in particular in the pulmonary system, while bleeding complications are infrequent. Here, we describe two critically ill COVID-19 patients admitted to our intensive care unit with different thromboelastometry and biomarker patterns.
Like
Comment
Share
